Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.
2.
Why breast cancer survivors don't take their medicine, and what can be done about it.
3.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
4.
C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.
5.
Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.
1.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
2.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
3.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
4.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
5.
What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Efficient Management of First line ALK-rearranged NSCLC - Part II
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation